Phase	Product/ Compound	Indication	Study	Results expected
IV	Bosentan	Combination bosentan & sildenafil in PAH	COMPASS -2	n/a
IV	Iloprost	Pulmonary Arterial Hypertension (improved Delivery system)	n/a	n/a
IV	Miglustat	GD1 patients switched from ERT to miglustat	MAINTENANCE	n/a
III	Actelion -1	Pulmonary Arterial Hypertension	SERAPHIN	n/a
III	Almorexant	Sleep disorders	RESTORA	n/a
III	Bosentan	Idiopathic Pulmonary Fibrosis	BUILD-3	H2 2009
III	Clazosentan	Vasospasm as consequence of subarachnoid hemorrhage (SAH)	CONSCIOUS-2	H2 2009
II	CRTH2 antagonist	Allergy	n/a	n/a
II	Miglustat	Cystic Fibrosis	n/a	H2 2008
II	PGI2 agonist	Pulmonary Arterial Hypertension	n/a	n/a
II	Renin inhibitor	Cardiovascular	n/a	n/a
I	S1P1 agonist	Immunology	n/a	2008